Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cediranib. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR known ✓ | P35968 | 11/20 | 0.89 |
| ▸ | FLT4 known ✓ | P35916 | 4/20 | 0.89 |
| ▸ | FLT1 known ✓ | P17948 | 3/20 | 0.89 |
| ▸ | PDGFRB known ✓ | P09619 | 2/20 | 0.89 |
| ▸ | KIT known ✓ | P10721 | 1/20 | 0.89 |
| ▸ | PDGFRA known ✓ | P16234 | 1/20 | 0.89 |
| ▸ | RET | P07949 | 4/20 | 0.89 |
| ▸ | TEK | Q02763 | 2/20 | 0.89 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.89 |
| ▸ | PLK4 | O00444 | 1/20 | 0.89 |
| ▸ | GAK | O14976 | 1/20 | 0.89 |
| ▸ | EPHB6 | O15197 | 1/20 | 0.89 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.89 |
| ▸ | ERN1 | O75460 | 1/20 | 0.89 |
| ▸ | STK10 | O94804 | 1/20 | 0.89 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.89 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.89 |
| ▸ | ABL1 | P00519 | 1/20 | 0.89 |
| ▸ | EGFR | P00533 | 1/20 | 0.89 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.89 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cediranib SCHEMBL63147 | 0.94 | KDR (1.00) | KDRRETFLT4FLT1PDGFRB | |
| Cediranib SCHEMBL29368143 | 0.94 | KDR (1.00) | KDRRETFLT4FLT1PDGFRB | |
| Cediranib SCHEMBL29351458 | 0.94 | KDR (1.00) | KDRRETFLT4FLT1PDGFRB | |
| Cediranib SCHEMBL29383181 | 0.94 | KDR (1.00) | KDRRETFLT4FLT1PDGFRB | |
| SCHEMBL1685423 | 0.94 | ABCB11 (1.00) | KDRRETFLT4FLT1PDGFRB | |
| SCHEMBL11953084 | 0.89 | KDR (0.84) | KDRRETFLT4FLT1PDGFRB | |
| SCHEMBL20077514 | 0.89 | KDR (0.89) | KDRRETFLT4FLT1PDGFRB | |
| SCHEMBL3198096 | 0.89 | KDR (0.89) | KDRRETFLT4FLT1PDGFRB | |
| SCHEMBL13471998 | 0.89 | KDR (0.89) | KDRRETFLT4FLT1PDGFRB | |
| SCHEMBL1401668 | 0.89 | KDR (0.89) | KDRRETFLT4FLT1PDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009094211-A1 | QUINAZOLINE COMPOUNDS AND METHODS OF TREATING CANCER | CONCERT PHARMACEUTICALS INC. (US) | 2009-07-30 | — | — | WO | disclosed |